Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.31 USD | +1.85% | +2.82% | -14.58% |
04-04 | Acumen Pharmaceuticals Signs Deal With Lonza to Manufacture Alzheimer's Treatment Drug | MT |
04-04 | Lonza Enters Manufacturing Agreement for Acumen’s Alzheimer’s Disease Drug Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.58% | 195M | |
+26.07% | 42.68B | |
-2.64% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.14% | 24.94B | |
-20.82% | 18.96B | |
+29.44% | 12.3B | |
-2.61% | 11.95B | |
-1.14% | 11.55B |
- Stock Market
- Equities
- ABOS Stock
- News Acumen Pharmaceuticals, Inc.
- Acumen Pharmaceuticals : Stifel Initiates Acumen Pharmaceuticals at Buy Rating With $27 Price Target